Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 516.02M | 313.26M | 208.05M | 167.04M | 121.62M |
Gross Profit | 143.21M | 95.87M | 47.48M | 35.63M | 30.26M |
EBITDA | 63.15M | 53.83M | 27.07M | 16.41M | 12.86M |
Net Income | 49.54M | 29.35M | 22.60M | 4.71M | 2.42M |
Balance Sheet | |||||
Total Assets | 1.06B | 1.03B | 945.73M | 732.96M | 747.90M |
Cash, Cash Equivalents and Short-Term Investments | 347.16M | 181.32M | 173.22M | 110.28M | 167.05M |
Total Debt | 0.00 | 0.00 | 2.00M | 0.00 | 0.00 |
Total Liabilities | 350.54M | 355.40M | 291.12M | 100.94M | 114.20M |
Stockholders Equity | 713.02M | 673.72M | 654.62M | 632.01M | 633.70M |
Cash Flow | |||||
Free Cash Flow | 164.83M | 2.16M | 17.27M | -36.16M | -29.97M |
Operating Cash Flow | 165.23M | 8.48M | 30.99M | -34.41M | -26.22M |
Investing Cash Flow | -128.59M | -37.50M | 40.99M | 21.04M | 17.84M |
Financing Cash Flow | -10.24M | -10.24M | 7.00M | -6.40M | 0.00 |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | HK$60.85B | 6.20 | 14.62% | 4.95% | 1.21% | 2.15% | |
74 Outperform | HK$6.88B | 11.61 | 36.29% | 7.04% | 25.93% | 8.97% | |
72 Outperform | HK$293.12M | 5.46 | 7.16% | 3.82% | 64.05% | 67.30% | |
67 Neutral | $1.41B | 6.73 | 8.83% | 4.55% | -20.69% | -30.40% | |
58 Neutral | HK$14.28B | 4.63 | -3.01% | 6.75% | 3.67% | -54.16% | |
53 Neutral | HK$2.10B | 105.43 | 0.59% | ― | -21.05% | -87.68% |
Wuxi Sunlit Science & Technology Co., Ltd. has established a Nomination Committee to enhance its corporate governance by regulating the appointment of senior executives and optimizing the Board of Directors’ composition. This move is expected to streamline the selection process for directors and senior management, potentially improving the company’s operational efficiency and strengthening its market position.
Wuxi Sunlit Science & Technology Co., Ltd. has announced its annual general meeting scheduled for June 27, 2025, in Wuxi, Jiangsu Province, China. The meeting will address several key resolutions, including the approval of the company’s annual reports, financial statements, profit distribution plan, and the re-appointment of PricewaterhouseCoopers as the external auditor. This meeting is significant for stakeholders as it will determine the company’s financial strategies and governance policies for the upcoming year.
Wuxi Sunlit Science & Technology Co., Ltd. reported a significant financial performance improvement for the year ended December 31, 2024, with a 64.7% increase in revenue and a 68.9% rise in profit attributable to shareholders. The company also announced a change in the composition of its nomination committee, which may influence its corporate governance and strategic direction.
Wuxi Sunlit Science & Technology Co., Ltd. has announced a final cash dividend of RMB 0.08 per share for the financial year ending December 31, 2024. The dividend reflects the company’s commitment to returning value to its shareholders, with the payment date set for July 18, 2025, following shareholder approval on June 27, 2025. This announcement may impact the company’s market positioning by reinforcing investor confidence and potentially influencing stock performance.
Wuxi Sunlit Science & Technology Co., Ltd. has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The board has established four committees: Audit, Remuneration and Appraisal, Nomination, and Strategic, with specific directors assigned as chairmen and members of these committees. This announcement provides clarity on the governance structure of the company, potentially impacting its strategic decision-making and operational oversight.
Wuxi Sunlit Science & Technology Co., Ltd. has announced an upcoming board meeting on March 28, 2025, to discuss and approve the audited consolidated annual results for the year ending December 31, 2024. The meeting will also consider the recommendation of a final dividend, which could impact shareholder returns.